A Phase IIa Non-Blinded Study of Safety, Tolerability and Efficacy of S1B-408 in Women With Orgasmic Dysfunction
Latest Information Update: 31 Jul 2024
At a glance
- Drugs S1B 408 (Primary)
- Indications Anorgasmia
- Focus Therapeutic Use
- Sponsors S1 Biopharma
- 31 Jul 2024 New trial record